Immunoglobulins Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Publish Date: Dec 2018

Report Code: TMR1227A

Publisher: Transparency

Single User License: $5795

Explore Our Services

Already a member? Login here.

Report Highlights

Global Immunoglobulins Market: Overview

This report analyzes the current and future scenario of the global immunoglobulins market for the period 2018 to 2026. Rise in neurology, immunology, hematology, and other disease prevalence, high unmet medical needs, and rich pipeline are likely to be major drivers of the global immunoglobulins market during the forecast period.

The global immunoglobulins market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on applications, route of administration, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global immunoglobulins market.

Global Immunoglobulins Market: Key Segments

Based on application, the global immunoglobulins market has been segmented into neurology, immunology, hematology, and others. The segments have been analyzed based on available products used during the treatment of chronic diseases, and cost-effectiveness. In terms of route of administration, the global immunoglobulins market has been classified into intravenous, subcutaneous, and intramuscular. Based on end-user, the global immunoglobulins market has been divided into hospital, clinics, and homecare. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Global Immunoglobulins Market: Regional Outlook

In terms of region, the global immunoglobulins market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players operating in the global Immunoglobulins market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Shire, CSL Behring, Kedrion Biopharma Inc, Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc, Biotest AG, Sanquin, and LFB SA.

The global immunoglobulins market has been segmented as below:

Global Immunoglobulins Market, by Applications
Neurology
Immunology
Hematology
Others
Global Immunoglobulins Market, by Route Of Administration
Intravenous
Subcutaneous
Intramuscular
Global Immunoglobulins Market, by End-user
Hospital
Clinic
Homecare
Global Immunoglobulins Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

  • Table 1 : Global Immunoglobulins Market Value (US$ Mn) Forecast, by Applications, 2016–2026
  • Table 2 : Global Immunoglobulins Market Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 3 : Global Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 4 : Global Immunoglobulins Market Value (US$ Mn) Forecast, by Region, 2016–2026
  • Table 5 : North America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
  • Table 6 : North America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 7 : North America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 8 : North America Immunoglobulins Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 9 : Europe Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
  • Table 10 : Europe Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 11 : Europe Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 12 : Europe Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 13 : Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
  • Table 14 : Asia Pacific Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 15 : Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 16 : Asia Pacific Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 17 : Latin America Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
  • Table 18 : Latin America Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 19 : Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 20 : Latin America Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 21 : Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Applications, 2016–2026
  • Table 22 : Middle East & Africa Immunoglobulins Value (US$ Mn) Forecast, by Route of Administration, 2016–2026
  • Table 23 : Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 24 : Middle East & Africa Immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Figure 1 : Global Immunoglobulins Market Snapshot
  • Figure 2 : Global Immunoglobulins Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
  • Figure 3 : Global Immunoglobulins Market Snapshot, ROA
  • Figure 4 : Global Immunoglobulins Market Snapshot, ROA
  • Figure 5 : Global Immunoglobulins Market Value (US$ Mn) Forecast, 2016?2026
  • Figure 6 : Global Immunoglobulins Market Value Share, by Applications (2017)
  • Figure 7 : Global Immunoglobulins Market Value Share, by Route of Administration (2017)
  • Figure 8 : Global Immunoglobulins Market Value Share, by End-user (2017)
  • Figure 9 : Global Immunoglobulins Market Value Share, by Region (2017)
  • Figure 10 : Global Immunoglobulins Market Value Share Analysis, by Applications, 2017 and 2026
  • Figure 11 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Neurology, 2016–2026
  • Figure 12 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hematology, 2016–2026
  • Figure 13 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016-2026
  • Figure 14 : Global Immunoglobulins Market Attractiveness, by Applications, 2018–2026
  • Figure 15 : Global Immunoglobulins Market Value Share(%), by Route of Administration, 2017 and 2026
  • Figure 16 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Subcutaneous, 2016–2026
  • Figure 17 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intramuscular, 2016–2026
  • Figure 18 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Intravenous, 2016–2026
  • Figure 19 : Global Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 20 : Global Immunoglobulins Market Value Share(%), by End-user, 2017 and 2026
  • Figure 21 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital, 2016–2026
  • Figure 22 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinic, 2016–2026
  • Figure 23 : Global Immunoglobulins Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Homecare, 2016–2026
  • Figure 24 : Global Immunoglobulins Market Attractiveness, by End-user, 2018–2026
  • Figure 25 : Global Immunoglobulins Market Value Share Analysis, by Region 2017 and 2026
  • Figure 26 : Global Immunoglobulins Market Attractiveness, by Region, 2018–2026
  • Figure 27 : North America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 28 : North America Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
  • Figure 29 : North America Immunoglobulins Market Attractiveness, by Applications, 2018–2026
  • Figure 30 : North America Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
  • Figure 31 : North America Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 32 : North America Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
  • Figure 33 : North America Immunoglobulins Market Attractiveness, by End-user, 2018–2026
  • Figure 34 : North America Immunoglobulins Market Value Share (%), by Country, 2017 and 2026
  • Figure 35 : North America Immunoglobulins Market Attractiveness, by Country, 2018–2026
  • Figure 36 : Europe Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 37 : Europe Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
  • Figure 38 : Europe Immunoglobulins Market Attractiveness, by Applications, 2018–2026
  • Figure 39 : Europe Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
  • Figure 40 : Europe Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 41 : Europe Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
  • Figure 42 : Europe Immunoglobulins Market Attractiveness, by End-user, 2018–2026
  • Figure 43 : Europe Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 44 : Europe Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 45 : Latin America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 46 : Asia Pacific Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
  • Figure 47 : Asia Pacific Immunoglobulins Market Attractiveness, by Applications, 2018–2026
  • Figure 48 : Asia Pacific Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
  • Figure 49 : Asia Pacific Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 50 : Asia Pacific Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
  • Figure 51 : Asia Pacific Immunoglobulins Market Attractiveness, by End-user, 2018–2026
  • Figure 52 : Asia Pacific Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 53 : Asia Pacific Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 54 : Latin America Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 55 : Latin America Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
  • Figure 56 : Latin America Immunoglobulins Market Attractiveness, by Applications, 2018–2026
  • Figure 57 : Latin America Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
  • Figure 58 : Latin America Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 59 : Latin America Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
  • Figure 60 : Latin America Immunoglobulins Market Attractiveness, by End-user, 2018–2026
  • Figure 61 : Latin America Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 62 : Latin America Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 63 : Middle East & Africa Immunoglobulins Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
  • Figure 64 : Middle East & Africa Immunoglobulins Market Value Share (%), by Applications, 2017 and 2026
  • Figure 65 : Middle East & Africa Immunoglobulins Market Attractiveness, by Applications, 2018–2026
  • Figure 66 : Middle East & Africa Immunoglobulins Market Value Share (%), by Route of Administration, 2017 and 2026
  • Figure 67 : Middle East & Africa Immunoglobulins Market Attractiveness, by Route of Administration, 2018–2026
  • Figure 68 : Middle East & Africa Immunoglobulins Market Value Share (%), by End-user, 2017 and 2026
  • Figure 69 : Middle East & Africa Immunoglobulins Market Attractiveness, by End-user, 2018–2026
  • Figure 70 : Middle East & Africa Immunoglobulins Market Value Share (%), by Country/Sub-region, 2017 and 2026
  • Figure 71 : Middle East & Africa Immunoglobulins Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 72 : Global Immunoglobulins Market Share Analysis, by Company (2017)
  • Figure 73 : Research & Development Expenses (2017)
  • Figure 74 : Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 75 : Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 76 : Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 77 : Research and Development Expenses, 2014–2018
  • Figure 78 : Breakdown of Net Sales (% Share), by Region (2017–2018)
  • Figure 79 : Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
  • Figure 80 : Research and Development Expenses, 2013-2017
  • Figure 81 : Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 82 : Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 83 : Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 84 : Research and Development Expenses, 2013-2017
  • Figure 85 : Breakdown of Net Sales (% Share), by Region (2017)
  • Figure 86 : Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 87 : Breakdown of Net Sales (% Share), by Business Segment (2017)
  • Figure 88 : Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017
  • Figure 89 : Research and Development Expenses, 2013-2017
  • Figure 90 : Breakdown of Net Sales, by Business Segment, 2017
  • Figure 91 : Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
  • Figure 92 : Research & Development Cost, 2015–2017 (US$ Mn)
  • Figure 93 : Breakdown of Net Sales, by Business Segment, 2017
  • Figure 94 : Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
  • Figure 95 : Research & Development Cost, 2015–2017 (US$ Mn)
  • Figure 96 : Breakdown of Net Sales, by Business Segment, 2017
  • Figure 97 : Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
  • Figure 98 : Research & Development Cost, 2015–2017 (US$ Mn)
  • Figure 99 : Breakdown of Net Sales, by Business Segment, 2017
  • Figure 100 : Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
  • Figure 101 : Research & Development Cost, 2015–2017 (US$ Mn)
  • Figure 102 : Breakdown of Net Sales, by Business Segment, 2017
  • Figure 103 : Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2017
  • Figure 104 : Research & Development Cost, 2015–2017 (US$ Mn)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Immunoglobulins Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026